{"title":"用微型机器人和细菌机器人治疗癌症。","authors":"Aishani Pal, Ruchi Sonowane, Wusirika Ramakrishna","doi":"10.1007/s12033-025-01488-4","DOIUrl":null,"url":null,"abstract":"<p><p>Developing efficient medication delivery systems is a key area of research that will improve the efficacy of cancer treatments. As cancer cells have certain characteristics, it is crucial to precisely deliver chemotherapeutic drugs to the tumor microenvironment without harming healthy tissues. There has been a growing interest in exploiting biological agents to overcome the disadvantages of traditional cancer treatments in targeting and delivering drugs. These technologies utilize specific properties of the tumor microenvironment, such as the availability of excess glucose. This review discusses the current understanding of microrobots for cancer treatment with a special focus on bacteriobots. Bacteriobots are excellent candidates for smart cancer therapy because they can respond to particular cues from the tumor microenvironment. Similarly, microrobots include bacteriobots and other miniature materials/devices for the precise and specific targeting of cancer cells. Here, we discuss synthetic and biohybrid microrobots. It is imperative to make further technological advancements so that they can be employed on a large scale for cancer treatment.</p>","PeriodicalId":18865,"journal":{"name":"Molecular Biotechnology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Targeting Cancers with Microrobots and Bacteriobots.\",\"authors\":\"Aishani Pal, Ruchi Sonowane, Wusirika Ramakrishna\",\"doi\":\"10.1007/s12033-025-01488-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Developing efficient medication delivery systems is a key area of research that will improve the efficacy of cancer treatments. As cancer cells have certain characteristics, it is crucial to precisely deliver chemotherapeutic drugs to the tumor microenvironment without harming healthy tissues. There has been a growing interest in exploiting biological agents to overcome the disadvantages of traditional cancer treatments in targeting and delivering drugs. These technologies utilize specific properties of the tumor microenvironment, such as the availability of excess glucose. This review discusses the current understanding of microrobots for cancer treatment with a special focus on bacteriobots. Bacteriobots are excellent candidates for smart cancer therapy because they can respond to particular cues from the tumor microenvironment. Similarly, microrobots include bacteriobots and other miniature materials/devices for the precise and specific targeting of cancer cells. Here, we discuss synthetic and biohybrid microrobots. It is imperative to make further technological advancements so that they can be employed on a large scale for cancer treatment.</p>\",\"PeriodicalId\":18865,\"journal\":{\"name\":\"Molecular Biotechnology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Biotechnology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12033-025-01488-4\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12033-025-01488-4","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Targeting Cancers with Microrobots and Bacteriobots.
Developing efficient medication delivery systems is a key area of research that will improve the efficacy of cancer treatments. As cancer cells have certain characteristics, it is crucial to precisely deliver chemotherapeutic drugs to the tumor microenvironment without harming healthy tissues. There has been a growing interest in exploiting biological agents to overcome the disadvantages of traditional cancer treatments in targeting and delivering drugs. These technologies utilize specific properties of the tumor microenvironment, such as the availability of excess glucose. This review discusses the current understanding of microrobots for cancer treatment with a special focus on bacteriobots. Bacteriobots are excellent candidates for smart cancer therapy because they can respond to particular cues from the tumor microenvironment. Similarly, microrobots include bacteriobots and other miniature materials/devices for the precise and specific targeting of cancer cells. Here, we discuss synthetic and biohybrid microrobots. It is imperative to make further technological advancements so that they can be employed on a large scale for cancer treatment.
期刊介绍:
Molecular Biotechnology publishes original research papers on the application of molecular biology to both basic and applied research in the field of biotechnology. Particular areas of interest include the following: stability and expression of cloned gene products, cell transformation, gene cloning systems and the production of recombinant proteins, protein purification and analysis, transgenic species, developmental biology, mutation analysis, the applications of DNA fingerprinting, RNA interference, and PCR technology, microarray technology, proteomics, mass spectrometry, bioinformatics, plant molecular biology, microbial genetics, gene probes and the diagnosis of disease, pharmaceutical and health care products, therapeutic agents, vaccines, gene targeting, gene therapy, stem cell technology and tissue engineering, antisense technology, protein engineering and enzyme technology, monoclonal antibodies, glycobiology and glycomics, and agricultural biotechnology.